Expert discusses interoperable automation DDW SLAS2026 track
Kelly Bachovchin PhD, Customer Engagement Scientist, Collaborative Communications, will be speaking at the DDW track Creating Cures: The role of lab automation in successful drug discovery at SLAS2026.
He will discuss Interoperable Automation: Real-Time Dataflows to Close DMTA Cycles.
You can register your interest here.
For the third year running DDW is organising this series of seminars at SLAS International Conference and Exhibition. Based on the SLAS2026 theme of Catalyze Discovery, these will be available to visitors of SLAS2026 (7-11 February 2026, Boston, USA).
This programme, Creating Cures: The role of lab automation in successful drug discovery at SLAS2026 – will highlight innovative research using technology in drug development and will be held in the Ignite Theater on 9 and 10 February
Bachovchin joined CDD to begin her industrial career after completing her PhD in Chemistry at Northeastern University. Her research focused on synthesising and optimising small molecule compounds for the treatment of neglected tropical diseases. Before receiving her PhD, she also obtained a Master’s degree in Biotechnology and Bachelor’s degree in Molecular Biology, from Kean University.
The track is sponsored by Collaborative Drug Discovery (CDD), Brooks Automation and Thermo Fisher Scientific.
Let us know if you’re attending by registering your interest.
